Late presentation in HIV-infected injecting drug users - a huge challenge for the Romanian health-care system

被引:4
|
作者
Ianache, Irina [1 ]
Calistru, Petre [1 ,2 ]
Tardei, Gratiela [1 ]
Ruta, Simona [2 ,3 ]
Oprea, Cristiana [1 ,2 ]
机构
[1] Victor Babes Clin Hosp Infect & Trop Dis, Bucharest, Romania
[2] Carol Davila Univ Med & Pharm, Bucharest, Romania
[3] Stefan S Nicolau Inst Virol, Bucharest, Romania
来源
ROMANIAN JOURNAL OF LEGAL MEDICINE | 2016年 / 24卷 / 02期
关键词
HIV; IDUs; late presentation; MYCOBACTERIUM-TUBERCULOSIS; COINFECTION; DIAGNOSIS; PREVALENCE; DISEASE;
D O I
10.4323/rjlm.2016.122
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
Background. HIV-infected injecting drug users (HIV-IDUs) are a major challenge to the Romanian healthcare system due to their high morbidity, mortality and health-care costs. Objective. The aim of this study was to determine the prevalence of late presenters (LP) among HIV-IDUs admitted to "Victor Babes" Clinical Hospital for Infectious Diseases, Bucharest and to evaluate their demographic and clinical characteristics. Methods. We performed a prospective study on HIV-IDUs diagnosed with severe immunosuppression, admitted between January 2009 and December 2014. HIV-IDUs with CD4 cell counts <350/mm(3) were considered LP and those with CD4 to a tertiary facility <200/mm(3) were defined with advanced HIV disease (AHD). These two groups were compared to a group of the HIV-IDUs that was diagnosed early in the evolution of illness (CD4 cell count >350/mm(3)). Statistical analysis was performed using SPSS v 20.0. Results. Out of 495 HIV-IDUs admitted during the study period, 238 (48.0%) were LP and 168 (33.7%) had AHD. The proportion of LP increased from 37.5% in 2009 to 52.6% in 2014 (0<0.001). Almost all HIV-IDUs, regardless of CD4 cell count, were young males (413, 83.4%), from urban areas (453, 91.5%), unemployed (393, 79.3%) and with low educational level (381, 76.9%). The median age at drug use initiation of 19 years (IQR 16-24) and the median duration of drug use at 9 years (IQR 4-13), were similar in both groups. More than half of all HIV-IDUs initially used intravenous heroin and afterwards legal highs (339, 68.4%) and (81, 16.3%) used only legal highs. The median CD4 cell count for the LPs was 104 cells/mm(3) (IQR 24-220) and the median HIV viral load 5.44 log10 copies/mL (IQR 5.00-6.00). Compared to early diagnosed HIV-IDUs (257), late presenters were more frequently diagnosed with opportunistic infections, especially tuberculosis (117, 49.1%) vs. (37, 14.3%), p<0.0001 and severe bacterial infections, mainly respiratory (54, 22.6%) vs. (46, 17.8%) p=0.02. Mortality was higher in LPs versus early presenters IDU (7, 2.7%) vs. (54, 22.6%) respectively p<0.0001. Conclusions. The proportion of LPs among HIV-IDUs diagnosed in our hospital increased alarmingly over the last few years. There were no significant differences regarding socio-demographic characteristics and drug use behaviour between late presenters and those diagnosed early, but LPs were more often diagnosed with opportunistic infections and had a significantly higher mortality rate.
引用
收藏
页码:122 / 127
页数:6
相关论文
共 50 条
  • [1] Severe bacterial infections in HIV-infected injecting drug users from a Romanian health care facility
    Ianache, I.
    Popa, I.
    Horghidan, R.
    Ceausu, E.
    Oprea, C.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [2] Drug injection cessation among HIV-infected injecting drug users
    Bouhnik, AD
    Carrieri, MP
    Rey, D
    Spire, B
    Gastaut, JA
    Gallais, H
    Obadia, Y
    [J]. ADDICTIVE BEHAVIORS, 2004, 29 (06) : 1189 - 1197
  • [3] Serial position effects in HIV-infected injecting drug users
    Waldrop, D
    Ownby, RL
    Kumar, M
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2004, 114 (04) : 493 - 516
  • [4] Quality of life of HIV-infected injecting drug users in the era of HAART
    Surah, S.
    McLaughlin, J.
    Synott, C.
    Lee, S.
    Storeng, C.
    Keating, S.
    O'Dea, S.
    Adams, R.
    Keenan, E.
    Barry, M.
    Mulcahy, F.
    Walsh, C.
    Lyons, F.
    [J]. HIV MEDICINE, 2014, 15 : 66 - 66
  • [5] HIV-infected injection drug users: Health care utilization and morbidity
    Barash, Elizabeth Tesh
    Hanson, Debra L.
    Buskin, Susan E.
    Teshale, Eyasu
    [J]. JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2007, 18 (03) : 675 - 686
  • [6] Effect of cessation of drug misuse on the immune status of HIV-infected injecting drug users
    Radkowski, M
    Werezynska, T
    Laskus, T
    Kaminska, E
    Kuligowski, S
    [J]. ADDICTION BIOLOGY, 1997, 2 (01) : 95 - 99
  • [7] THE HIV-INFECTED EMERGENCY HEALTH-CARE PROFESSIONAL
    KNOPP, R
    ADAMS, J
    DERSE, A
    FRANASZEK, J
    GREEN, C
    ISERSON, K
    KALBFLEISCH, N
    KEIM, S
    SANDERS, A
    SCHMIDT, T
    SKLAR, D
    GOLDFRANK, L
    HEDGES, J
    [J]. ANNALS OF EMERGENCY MEDICINE, 1991, 20 (09) : 1036 - 1040
  • [8] RESTRICTIONS ON HIV-INFECTED HEALTH-CARE WORKERS
    LELEU, LA
    JEZUKAITIS, PT
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1995, 162 (09) : 498 - 499
  • [9] RESTRICTIONS ON HIV-INFECTED HEALTH-CARE WORKERS
    VLAHAKIS, EG
    BRIEGER, GM
    MACGIBBON, AL
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1995, 162 (02) : 109 - 109
  • [10] Nonadherence among HIV-Infected injecting drug users: The impact of social instability
    Bouhnik, AD
    Chesney, M
    Carrieri, P
    Gallais, H
    Moreau, J
    Moatti, JP
    Obadia, Y
    Spire, B
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 : S149 - S153